MoneyWorks4Me

The sales surged to Rs. 3024.05 millions, up 25.85% for the December 2022 quarter as against Rs. 2402.97 millions during the corresponding quarter previous year.Net profit surges 96.46% to Rs. 292.20  millions  from Rs. 148.73 millions in the quarter ended December 2022.Operating Profit saw a handsome growth to 642.69 millions from 615.55 millions in the quarter ended December 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 3024.05 2402.97 25.85 8614.75 7122.71 20.95 9880.90 8565.78 15.35
Other Income 83.58 79.87 4.65 232.93 217.04 7.32 417.16 231.28 80.37
PBIDT 642.69 615.55 4.41 1890.43 1804.89 4.74 2361.90 2036.24 15.99
Interest 223.83 237.29 -5.67 703.44 720.50 -2.37 955.33 1002.16 -4.67
PBDT 418.86 361.34 15.92 1186.99 1067.47 11.20 1389.65 1034.08 34.39
Depreciation 154.25 212.61 -27.45 480.78 491.92 -2.26 1309.70 872.92 50.04
PBT 264.61 148.73 77.91 706.21 575.55 22.70 79.95 161.16 -50.39
TAX -27.59 0.00 0.00 -27.59 0.78 -3637.18 137.05 205.16 -33.20
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -109.17 94.76 -215.21
PAT 292.20 148.73 96.46 733.80 574.77 27.67 -57.10 -44.00 29.77
Equity 590.87 590.87 0.00 590.87 590.87 0.00 590.87 590.87 0.00
PBIDTM(%) 21.25 25.62 -17.03 21.94 25.34 -13.40 23.90 23.77 0.55
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..